Health FDA Approves Key Treatments for Diabetes, Ulcerative Colitis, and Alzheimer’s Healthcare advancements continue to make headlines as significant regulatory approvals were announced in the week of October 12, 2025. The U.S. Food and Drug... Editorial6 days ago
Politics HSBC Downgrades AbbVie to Hold Amid Mixed Analyst Ratings Shares of AbbVie (NYSE: ABBV) have been downgraded from a buy to a hold rating by HSBC, as reported in a research note sent... Editorial4 October, 2025
Business Vigilare Wealth Management Reduces AbbVie Holdings by 15.4% Vigilare Wealth Management has decreased its stake in AbbVie Inc. (NYSE: ABBV) by 15.4%, selling 429 shares during the second quarter of 2023. The... Editorial1 October, 2025